ArticleBiomolecules & biomedicine2026
Pretreatment comprehensive nutritional index predicts survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery.
Article in Biomolecules & biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nutritional status significantly influences treatment tolerance and long-term outcomes in patients with locally advanced rectal cancer (LARC); however, individual nutritional markers may not fully capture overall nutritional reserves. This study aimed to evaluate the prognostic value of a comprehensive nutritional index (CNI), derived from principal component analysis, in patients with LARC undergoing neoadjuvant chemoradiotherapy (NCRT) followed by surgical intervention. We conducted a retrospective analysis of 336 patients with LARC who received NCRT followed by surgery between 2014 and 2019. The CNI was constructed using body mass index, usual body weight percentage, total lymphocyte count, serum albumin, and hemoglobin levels. Patients were categorized into low- and high-CNI groups based on an outcome-oriented cut point, and survival outcomes were assessed through Kaplan-Meier analysis and Cox regression. Patients with lower CNI scores exhibited significantly poorer overall survival and disease-free survival compared to those with higher CNI scores. Furthermore, CNI remained independently associated with both endpoints after adjusting for established pathological factors, including tumor regression grade and ypN stage. A nomogram that integrates CNI, tumor regression grade, and ypN stage demonstrated favorable discrimination and calibration during internal validation. These findings support the use of pretreatment CNI as a practical nutritional composite associated with prognosis in LARC patients treated with NCRT, and the proposed nomogram may enhance individualized risk estimation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.